Clinical Trial Update: Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC). [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for seladelpar in adult liver transplant recipients with ischemic cholangiopathy (SELIC); study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cholangiopathy

Drugs mentioned

• Seladelpar (seladelpar)

Snippet

Sponsor: University of California, San Diego | Conditions: Liver Transplant; Complications, Ischemic Cholangiopathy | Phase 2 | Status: NOT_YET_RECRUITING